Format

Send to:

Choose Destination
See comment in PubMed Commons below
Urol Clin North Am. 2008 Feb;35(1):91-9; vii.

Re-imagining interstitial cystitis.

Author information

  • 1Hospital of the University of Pennsylvania, 9 Penn Tower, Philadelphia, PA 19104, USA. hannop@uphs.upenn.edu

Abstract

Since the postulation of an "antiproliferative factor" in 1998 and a description, six years later, of this putative central protein in the etiologic pathway of the painful bladder syndrome/interstitial cystitis, there have been no dramatic breakthroughs in the field. Although much potentially exciting work is in progress with regard to epidemiology, etiology, and clinical treatment, many clinicians and researchers have used this hiatus to take another look at what exactly is being studied and how the syndrome should be approached. This article explores some of the current "hot-button" issues of definition and nomenclature that have formed the basis of many international meetings in the last 5 years.

PMID:
18061027
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk